Latest filing published 25 Jan 2018 for Biohaven Pharmaceutical Holding Co Ltd., €657k.
Filing timeline
BuySaleInsider track record
Portage Biotech Inc.: trading record in brief
All filings by Portage Biotech Inc. on record concern Biohaven Pharmaceutical Holding Co Ltd. We count 10 filings; the first trade dates from 3 January 2018 and the latest from 23 January 2018.
On the market, this insider has only sold: 10 sales, €6.2M in total.
The record was last updated on 25 January 2018 with an open-market sale (€862k) in Biohaven Pharmaceutical Holding Co Ltd. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Portage Biotech Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,277 shares@ US$33.150.0% of flowCommon SharesSEC:0001393905-18-000022:1
- 35,119 shares@ US$30.030.0% of flowCommon StockSEC:0001393905-18-000021:0
- 24,277 shares@ US$33.15212.5% of flowCommon StockSEC:0001393905-18-000021:1
- 22,996 shares@ US$30.030.0% of flowCommon StockSEC:0001393905-18-000009:0
- 5,728 shares@ US$30.020.0% of flowCommon StockSEC:0001393905-18-000009:1
- 56,157 shares@ US$30.080.0% of flowCommon StockSEC:0001393905-18-000009:2
- 4,350 shares@ US$28.620.0% of flowCommon StockSEC:0001393905-18-000003:0
- 35,650 shares@ US$28.610.0% of flowCommon StockSEC:0001393905-18-000001:0
8 of 8 declarations
